Track the ABEL CABRERIZO EXTREMERA stock price and the full management transaction log of the company, a publicly traded company based in Spain. Shares are listed on ES ES, under the supervision of CNMV. Operating in the Health Care sector, ABEL CABRERIZO EXTREMERA has logged 1 insider filings. Market capitalisation: €210.7m. The latest transaction was reported on 22 June 2022 (Sale). Among the most active insiders: Abel Cabrerizo Extremera. Every trade is accessible without an account.
Analysts rate ABEL CABRERIZO EXTREMERA Strong Buy (bullish), based on 3 analysts. Average price target: €4.83.
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
1 of 1 declaration